Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 16, 2025World Journal of Current Medical and Pharmaceutical ResearchOpen Access

A Review on: Kearns-Sayre Syndrome (KSS)

View Full Paper
Ask AI
Bookmark
Share

Authors

VTVimalavathi ThentuRKRamu KowluENEswara Rao Nalla

Discussion

Loading...

Member takes

Overview

This review examines mitochondrial disorders impacting quality of life in Kearns-Sayre syndrome patients, highlighting symptoms and treatments.

Key Points

  • Kearns-Sayre syndrome causes significant muscle weakness and cardiac conduction defects, impacting patients' lives.
  • Patients may experience symptoms like progressive external ophthalmoplegia and pigmentary retinopathy before age 20.
  • Diagnosis involves genetic testing and imaging studies to confirm mitochondrial involvement in symptoms.
  • Supportive treatment options aim to improve quality of life and address multiple system complications.

Cite This Study

Thentu et al. (2025) studied this question.

synapsesocial.com/papers/68c235fdb210217d64772edchttps://doi.org/10.37022/wjcmpr.v7i2.362
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Fatal pneumonia in a patient with Kearns-Sayre syndrome case report and literature review2025
  2. 2Crucial Role of Early Detection in Managing Heart Failure in Kearns-Sayre Syndrome: A Case Report2025
  3. 3Genotype–Phenotype Correlations in Chinese Pediatric Patients With Single Large‐Scale Mitochondrial <scp>DNA</scp> Deletion Disorders2025
  4. 4Follow-up of a child with kearns-sayre syndrome and implanted pacemaker: a case report2025
  5. 5Marinesco–Sjögren Syndrome: A Novel SIL1 Variant with In Silico Analysis and Review of the Literature2025